A pair of investor calls on Jan. 22 added clarity to the rapidly evolving cardiac ablation market with Abbott Laboratories and Johnson & Johnson providing updates on their pulsed field ablation ...

The Clarivate e-book highlights new medtech breakthroughs in the pulsed field ablation (PFA) market, forecasting its future growth and showcasing the technology's potential to transform the ...

Farapulse, Boston Scientific’s pulsed field ablation product, fueled year-over-year growth of nearly 171% in the fourth ...

In 2024, Abbott's EP business demonstrated strength thanks to its preferred mapping systems, even though it is late to market with its own pulsed field ablation technology. However, EP growth ...

One year into the U.S. launch of pulsed field ablation systems from Boston Scientific and Medtronic ... divided between Boston Scientific (58%), Medtronic (28%), J&J (11%), and Abbott (3%). In 2026, ...

using three commercial contact-force sensing focal catheters with the Centauri™ System’s optimized WAVE1™ pulsed field ablation (PFA) waveform. The system, which has since received CE mark ...

New e-book explores transformative medtech advancements in pulsed field ablation for atrial fibrillation treatment. LONDON, Feb. 4, 2025 /CNW/ -- Clarivate Plc (NYSE:CLVT) a leadi ...

LONDON, Feb. 4, 2025 /CNW/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence and BioWorld by Clarivate, today published a new e-book, Pulsed field ablation ...